Lifeline Biotechnologies, Inc. (LLBO)
OTCMKTS · Delayed Price · Currency is USD
0.0003
-0.0004 (-57.14%)
Sep 10, 2026, 3:18 PM EST
Lifeline Biotechnologies Market Cap
Lifeline Biotechnologies has a market cap or net worth of $2.17 million as of September 10, 2026. Its market cap has decreased by -16.67% in one year.
Market Cap
2.17M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 2.17M, a decrease of -88.54%. That is a compound annual growth rate of -9.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 2.17M | -28.57% |
| Dec 31, 2025 | 3.04M | 600.00% |
| Dec 31, 2024 | 434.89K | -35.07% |
| Dec 28, 2023 | 669.78K | -33.33% |
| Dec 30, 2022 | 1.00M | 50.00% |
| Dec 31, 2021 | 669.78K | -60.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Golden Valley Development | 2.94M |
| Affiliated Resources | 2.91M |
| Oncology Pharma | 2.51M |
| Atlantica | 2.46M |
| Aimrite Holdings | 2.39M |
| WeCapital Holdings | 2.11M |
| AI Energy | 2.09M |
| Fuss Brands | 1.72M |